Carlyle Group Inc.
SEC Form 4 insider trading activity
Carlyle Group Inc. has filed 6 SEC Form 4 filings (14 transaction rows) across 2 companies, including MDLN, SARO, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Mar 12, 2026.
On the most recent filing, Carlyle Group Inc. is listed as 10% Owner at Medline Inc. Inside the rolling window, Carlyle Group Inc. reported no open-market purchases and 4 open-market sales totaling $3.7B in MDLN and SARO. The largest disclosed transaction in the window is a sale of 48,246,588 SARO shares on Jan 29, 2026, worth $1.5B.
Companies traded
Other insiders at MDLN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.7B
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Carlyle Group Inc. made?
Carlyle Group Inc. has filed 6 SEC Form 4 filings (14 transaction rows) across 2 companies, including MDLN, SARO since 2025.
Which companies does Carlyle Group Inc. trade?
Carlyle Group Inc. has filed SEC Form 4 disclosures for 2 companies, including MDLN, SARO.
When was Carlyle Group Inc.'s most recent SEC Form 4 filing?
Carlyle Group Inc.'s most recent SEC Form 4 filing on Tracefour is dated Mar 12, 2026.
What is Carlyle Group Inc.'s total buy and sell value in the current window?
Inside the rolling retention window, Carlyle Group Inc. bought $0 and sold $3.7B based on SEC Form 4 filings.
What was Carlyle Group Inc.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 48,246,588 SARO shares on 2026-01-29, worth $1.5B, per SEC Form 4 filings.